Read + Share
Amedeo Smart
Independent Medical Education
Liang MI, Chen L, Hershman DL, Hillyer GC, et al. Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients. Gynecol Oncol 2020 Dec 27. pii: S0090-8258(20)34218.PMID: 33375989
Email
LinkedIn
Facebook
Twitter
Privacy Policy